Contact Lenses Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Contact Lenses stocks.

Contact Lenses Stocks Recent News

Date Stock Title
Jul 3 JNJ Johnson & Johnson: A Lot Of Moving Parts, But Perhaps Finally Lurching In The Right Direction
Jul 3 JNJ Johnson & Johnson: Put Selling Can Yield A Potential 9.8% Return
Jul 3 JNJ How Small Biotech Halozyme, With A 41% Run, Is Getting Under Your Skin
Jul 3 JNJ Health Canada Authorizes RYBREVANT® (amivantamab) in Combination with Carboplatin and Pemetrexed as the Only Targeted First-line Treatment Approved for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Jul 3 ALC Alcon buys Belkin Vision for $81M upfront
Jul 3 JNJ Johnson & Johnson gains FDA and EC approvals for TB treatment
Jul 3 JNJ Johnson & Johnson reports data from Phase III multiple myeloma treatment trial
Jul 2 JNJ Johnson & Johnson's Cell Therapy Carvykti Shows Better Survival Rate In Pretreated Blood Cancer Patients
Jul 2 JNJ Court Rules Against Johnson & Johnson In Talcum Powder Cancer Study Case
Jul 2 JNJ J&J says Carvykti beat standard drugs in late-stage blood cancer trial
Jul 2 JNJ CARVYKTI® (ciltacabtagene autoleucel) achieved statistically significant and clinically meaningful improvement in overall survival in landmark CARTITUDE-4 study
Jul 2 ALC Alcon closes $81m deal to buy Belkin Vision with $65m in cash
Jul 1 JNJ 5 Biggest Winners, 5 Biggest Losers From Dow Jones Industrial Average In First Half 2024
Jul 1 EYE National Vision Welcomes Mark Banner as New Chief Stores Officer
Jul 1 JNJ J&J looks to challenge argenx’s Vyvgart with positive Phase III data
Jul 1 EYE National Vision (EYE) Gains Market Share Despite Macro Woes
Jul 1 JNJ 3 Magnificent Stocks Retirees Can Buy and Hold Forever
Jul 1 JNJ Merck (MRK) Gets CHMP Nod for PAH Drug Winrevair in Europe
Jun 30 JNJ 2 Unstoppable Dividend Stocks to Buy if There's a Stock Market Sell-Off
Jun 29 JNJ J&J talc claimants lose bid to block company's bankruptcy bid
Contact Lenses

Contact lens, or simply contacts, are thin lenses placed directly on the surface of the eyes. Contact lenses are ocular prosthetic devices used by over 150 million people worldwide, and they can be worn to correct vision or for cosmetic or therapeutic reasons. In 2010, the worldwide market for contact lenses was estimated at $6.1 billion, while the US soft lens market was estimated at $2.1 billion. Multiple analysts estimated that the global market for contact lenses would reach $11.7 billion by 2015. As of 2010, the average age of contact lens wearers globally was 31 years old, and two-thirds of wearers were female.People choose to wear contact lenses for many reasons. Aesthetics and cosmetics are the main motivating factors for people who want to avoid wearing glasses or to change the appearance of their eyes. Others wear contact lenses for functional or optical reasons. When compared with spectacles, contact lenses typically provide better peripheral vision, and do not collect moisture (from rain, snow, condensation etc.) or perspiration. This can make them preferable for sports and other outdoor activities. Contact lens wearers can also wear sunglasses, goggles, or other eyewear of their choice without having to fit them with prescription lenses or worry about compatibility with glasses. Additionally, there are conditions such as keratoconus and aniseikonia that are typically corrected better with contact lenses than with glasses.

Browse All Tags